You mean Novartis backing another product it was associated with already....... which ended up failing entirely?
Their judgement is indeed questionable.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-321
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.045(3.07%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $5.177M | 3.686M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 10842 | $1.42 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 3817 | 5 |
View Market Depth
| Last trade - 12.50pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |